Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AirSnore is a consumer sleep-health brand focused on over-the-counter anti-snoring products, primarily a mandibular advancement mouthpiece and companion drops marketed to improve airflow during sleep. The brand appears to operate as a commercial wellness/medical-device business rather than a drug-development biotech or pharmaceutical company. Public-facing materials position AirSnore as a simple at-home solution for snoring reduction and better sleep, sold directly online across multiple geographies. Available evidence indicates the brand is associated with Wolfson Brands (UK) Ltd., an active private company based in Glasgow, Scotland. For biotech diligence purposes, AirSnore should be classified as a commercial consumer health/device brand with no evident R&D pipeline, therapeutic platform, or clinical-stage drug assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AirSnore.